| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 01/21/2010 | DE102005020083B4 Verfahren und Software zum Extrahieren chemischer Daten Methods and software to extract chemical data |
| 01/21/2010 | DE10004815B4 Menschliche intestinale Natriumphosphat-Kotransporter Human intestinal sodium phosphate cotransporter |
| 01/21/2010 | CA2736311A1 Novel use application of sugar chain-recognizing receptor |
| 01/21/2010 | CA2732786A1 Method and apparatus for non-invasive analysis of saliva |
| 01/21/2010 | CA2731216A1 Compositions for the detection and treatment of colorectal cancer |
| 01/21/2010 | CA2731212A1 System and method of detecting disease in mammal |
| 01/21/2010 | CA2731197A1 Method for inhibiting corrosion |
| 01/21/2010 | CA2731137A1 Automatic information transfer by color encoded fields |
| 01/21/2010 | CA2731134A1 Novel method for measuring insulin resistance |
| 01/21/2010 | CA2731129A1 Cancerous disease modifying antibodies |
| 01/21/2010 | CA2731086A1 Non-invasive fetal rhd genotyping from maternal whole blood |
| 01/21/2010 | CA2731065A1 Diagnostics for membranous nephropathy |
| 01/21/2010 | CA2731040A1 Ignition interlock breathalyzer |
| 01/21/2010 | CA2730796A1 Aptamer against il-17 and use thereof |
| 01/21/2010 | CA2730785A1 Modulation of gm98 (mrf) in remyelination |
| 01/21/2010 | CA2730620A1 Human cytomegalovirus neutralising antibodies and use thereof |
| 01/21/2010 | CA2730615A1 Pacap signaling pathway modulators for treating inflammatory skin diseases with a neurogenic component, and more particularly rosacea and composition containing them |
| 01/21/2010 | CA2730614A1 Signatures and pcdeterminants associated with prostate cancer and methods of use thereof |
| 01/21/2010 | CA2730537A1 Strip connectors for measurement devices |
| 01/21/2010 | CA2730369A1 Compositions and methods for modulating nod-like receptor activity and uses thereof |
| 01/21/2010 | CA2729996A1 Method and device for producing organic compounds containing metal |
| 01/21/2010 | CA2729899A1 Methods for systematic control of protein stability |
| 01/21/2010 | CA2729559A1 Self-assembling multicellular bodies and methods of producing a three-dimensional biological structure using the same |
| 01/21/2010 | CA2729219A1 Kinase substrates |
| 01/21/2010 | CA2728574A1 Cancer diagnosis based on levels of antibodies against globo h and its fragments |
| 01/21/2010 | CA2727855A1 Means and methods diagnosing gastric bypass and conditions related thereto |
| 01/20/2010 | EP2146210A1 Methods of using A G protein-coupled receptor to identify peptide YY (PYY) secretagogues and compounds useful in the treatment of conditions modulated by PYY |
| 01/20/2010 | EP2146209A1 Neurodegenerative markers for Alzheimer's disease |
| 01/20/2010 | EP2146208A1 Kit for deciding degree of malignancy in prostate cancer and method of using the same |
| 01/20/2010 | EP2146207A1 Measurement reagent, immune nephelometry using the same, and analyte analysis tool |
| 01/20/2010 | EP2146206A1 Detection of blood plasma schizadrin b of dissipating blood stasis botanical |
| 01/20/2010 | EP2146199A1 Fluid identification method and fluid identification apparatus |
| 01/20/2010 | EP2145965A1 Multiplex quantification of nucleic acids in diseased cells |
| 01/20/2010 | EP2145961A2 Porcine adenovirus type 3 genome |
| 01/20/2010 | EP2145902A2 Tyrosine phosphorylation sites and antibodies specific for them |
| 01/20/2010 | EP2145899A1 RS virus detecting kit using anti-RS virus monoclonal antibody, immuno-chromatographic test device, and new anti-RS virus monoclonal antibody |
| 01/20/2010 | EP2145897A2 Therapeutic methods and compositions based on serrate proteins and nucleic acids |
| 01/20/2010 | EP2145579A1 System and Method for Optical Continuous Detection of an Analyte in Bloodstream |
| 01/20/2010 | EP2145193A1 Methods and compositions for upregulation of gata activity |
| 01/20/2010 | EP2145192A1 Methods for measuring platelet reactivity of individuals treated with drug eluting stents |
| 01/20/2010 | EP2145191A1 Method for determining amino-terminal proanp in patients having a cardiac disease or being suspected of developing or having a cardiac disease |
| 01/20/2010 | EP2145190A1 Use of timp-1 as a marker for colorectal cancer |
| 01/20/2010 | EP2145189A2 Papillomavirus pseudoviruses for detection and therapy of tumors |
| 01/20/2010 | EP2145188A1 Detection her-2/neu protein from non-isolated circulating cancer cells and treatment |
| 01/20/2010 | EP2145187A1 Periodic acid schiff staining with detection in the infrared range |
| 01/20/2010 | EP2145186A1 Apparatus and methods for the detection of plasma metanephrines |
| 01/20/2010 | EP2145185A2 Multianalyte assay |
| 01/20/2010 | EP2145184A1 Use of slim-1 in the assessment of heart failure |
| 01/20/2010 | EP2145183A2 Compound profiling method |
| 01/20/2010 | EP2145182A2 Biomarkers for multiple sclerosis |
| 01/20/2010 | EP2145181A1 Methods for the diagnosis and risk assessment of plasmalogen deficiency mediated diseases of aging |
| 01/20/2010 | EP2145180A1 Comparative sequence analysis processes and systems |
| 01/20/2010 | EP2145179A2 Process for detecting gaseous halogenated compounds |
| 01/20/2010 | EP2145091A2 Liquid level and composition sensing systems and methods |
| 01/20/2010 | EP2145025A1 A rapid, semi-automated method to detect respiratory virus infected cells in direct specimens |
| 01/20/2010 | EP2145019A1 Functional toll-like receptors (tlr) on melanocytes and melanoma cells and uses thereof |
| 01/20/2010 | EP2145018A2 Organism identification panel |
| 01/20/2010 | EP2145017A2 Method for detecting and/or isolating mycobacteria |
| 01/20/2010 | EP2145014A1 Agents that reduce neuronal overexcitation |
| 01/20/2010 | EP2145003A2 Polynucleotides and polypeptides involved in gestational malaria, and biological applications |
| 01/20/2010 | EP2144996A1 Carbon and nitrogen-regulating gene and protein and modulation thereof |
| 01/20/2010 | EP2144933A2 Anti-amyloid antibodies and their use in diagnosis and therapy of amyloid diseases |
| 01/20/2010 | EP2144622A1 Calcium flux as a pharmacoefficacy biomarker for inhibitors of histone deacetylase |
| 01/20/2010 | EP2144561A1 Mr methods of grading a tumor using an imaging medium that comprises hyperpolarised 13c-pyruvate |
| 01/20/2010 | EP1977246B1 Na+, k+-atpase expression in cervical dysplasia and cancer |
| 01/20/2010 | EP1946109B1 Method for detecting autoantibodies formed in rheumatoid arthritis |
| 01/20/2010 | EP1913394B1 Test system for detecting salmonella |
| 01/20/2010 | EP1913377B1 Ultrasonic document inspection system |
| 01/20/2010 | EP1902319B1 Diagnostic method for brain damage-related disorders |
| 01/20/2010 | EP1891443B1 Method for screening anticancer substances, set or kit for implementing said method |
| 01/20/2010 | EP1861418B1 T cd4+ epitopes of type i and ii latency antigens of the epstein-barr virus, which can be recognised by the majority of individuals in the caucasian population and applications thereof |
| 01/20/2010 | EP1779115B1 Method for detecting gluten |
| 01/20/2010 | EP1774332B1 Immune response assessment method |
| 01/20/2010 | EP1623204B1 Method and apparatus for detection of trace volatiles |
| 01/20/2010 | EP1575502B1 Compositions and methods involving nuclear hormone receptor site ii |
| 01/20/2010 | EP1571211B1 Antibodies against lesional tissues |
| 01/20/2010 | EP1507869B1 Improved receptor detection |
| 01/20/2010 | EP1507797B1 Inhibitors of proteins from the rho-gef family |
| 01/20/2010 | EP1456667B2 Method of mass spectrometry |
| 01/20/2010 | EP1404880B1 Method for identifying nucleic acid molecules amplified in a polymerase chain reaction |
| 01/20/2010 | EP1397679B1 Clinically intelligent diagnostic devices and methods |
| 01/20/2010 | EP1381861B1 Processes for producing coated magnetic microparticles and uses thereof |
| 01/20/2010 | EP1379272B1 Monoclonal antibodies directed against molecular mimetics of meningococcal b epitopes |
| 01/20/2010 | EP1342070B1 Method for detecting a gas using an infrared gas analyzer and gas analyzer suitable for carrying out said method |
| 01/20/2010 | EP1340055B1 Method for determining component flow rates for a multiphase flow |
| 01/20/2010 | EP1295117B1 Testgas detector for a leak detection device comprising a sensor for helium or hydrogen |
| 01/20/2010 | EP1277053B1 Device and process for lateral flow saliva testing |
| 01/20/2010 | EP1257649B1 Corynebacterium glutamicum genes encoding metabolic pathway proteins |
| 01/20/2010 | EP1204870B1 Method for determining physiological effects of hemoglobin |
| 01/20/2010 | EP1188830B1 Novel hemopoietin receptor protein ,nr10 |
| 01/20/2010 | EP1027608B1 Protein fragment complementation assays |
| 01/20/2010 | EP0768529B1 METHOD OF DETERMINING ß-(D)-GLUCAN |
| 01/20/2010 | EP0497784B2 Quantitation of nucleic acids using the polymerase chain reaction |
| 01/20/2010 | CN201388225Y Test paper type health-care mobile phone |
| 01/20/2010 | CN201387677Y Water pollution tester |
| 01/20/2010 | CN201387428Y ELISA plate locating device |
| 01/20/2010 | CN201387427Y Target base of concrete early-age shrinkage tester |
| 01/20/2010 | CN201387426Y Concrete early-age contractility measuring instrument displacement probe fixing device |
| 01/20/2010 | CN201387425Y Numerical control disc-type liquid limit device |
| 01/20/2010 | CN201384497Y Electronic blood glucose meter |